Gene expression profiling and subgroup identification of oligodendrogliomas

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genomics

Background:

• Distinguishing between low-grade astrocytomas and oligodendrogliomas (WHO grade II) is histologically challenging.
• Tumors with mixed astrocytic and oligodendroglial differentiation present particular diagnostic difficulties.
• Genetic markers like LOH 1p/19q and TP53 mutations are associated with these tumor types.

Purpose of the Study:

• To investigate differences in gene expression profiles between oligodendrogliomas and low-grade astrocytomas.
• To identify specific genes that can differentiate these two tumor types.
• To explore the relationship between gene expression patterns and clinical outcome in oligodendrogliomas.

Main Methods:

• Gene expression profiling using a cDNA array of 1176 cancer-related genes.
• Analysis of 17 oligodendrogliomas (with LOH 1p/19q) and 15 low-grade astrocytomas (with TP53 mutations).
• Immunohistochemistry for Jun-D and statistical analyses including partial least-squares and clustering.

Main Results:

• Identified 40 genes with higher and 39 genes with lower expression in oligodendrogliomas compared to astrocytomas.
• Demonstrated perfect separation of oligodendrogliomas from astrocytomas and normal white matter using differentially expressed genes.
• Found distinct gene expression subgroups within oligodendrogliomas correlating with significantly different patient survival rates.

Conclusions:

• Oligodendrogliomas and low-grade astrocytomas exhibit distinct gene expression profiles.
• Gene expression patterns can reliably differentiate between these gliomas.
• Subgrouping of oligodendrogliomas based on gene expression predicts clinical outcome, highlighting therapeutic implications.